WHO ICTRP trial

The influence of bupivacaine liposome application in sacral erector spinae plane…

ChiCTR2500106416 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting

Key facts

Trial ID ChiCTR2500106416
Public title The influence of bupivacaine liposome application in sacral erector spinae plane block (SESPB) on postoperative pain and analgesic needs of patients undergoing mixed hemorrhoid surgery
Scientific title The influence of bupivacaine liposome application in sacral erector spinae plane block (SESPB) on postoperative pain and analgesic needs of patients undergoing mixed hemorrhoid surgery
Primary sponsor Fuyang City People's Hospital
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Not Recruiting
Study type Interventional study
Phase 4
Countries China
Conditions Mixed hemorrhoid
Interventions SESPB group:After the operation, PCIA analgesia was performed.Ultrasound-guided median approach SEPSB (30 mL bupivacaine liposome mixture. The composition of bupivacaine liposome mixture: 266 mg of bupivacaine liposome + 10 ml of normal…
Registration date Jul 23, 2025
Target size SESPB group:38;Control group:38
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations